XILLIX FDA APPROVED Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XILLIX FDA APPROVED

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Garry K. who wrote (280)	6/27/1998 6:55:00 PM
From: Edward W. Richmond	Read Replies (2) of 572

Garry, when I had just about given up on the stock(not the product), I start to see some positive analyses of the company. My June 26th copy of the "Investment Reporter" arrived yesterday. It contains a rating on biotechnology stocks. Sure enough, there is a rating on Xillix. Xillix, one of three choice Canadian junior biotechs rated, is evaluated as a "speculative buy". In my opinion, the Investment Reporter is the best of the 11 newsletters to which I subscribe. I take their ratings, which tend to be conserevative, very seriously. I will review my notes on the AGM and post a summary. I'm happy I didn't sell on Thursday. I'm prepared to give the company more time to get greater marketing momentum. Regards, Ed

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next